^ Back to Top

BPJ 26 March 2010

Best Practice Journal

Falls in older people: causes and prevention

Approximately one-third of New Zealander’s aged over 65 years fall each year and this can result in considerable morbidity. Management is guided by the cause of the fall. Falls prevention interventions should be individually targeted. View Article

Driving rules and assessment for older people

The incidence of medical conditions that can affect safe driving increases with age. Older people should be regularly assessed for their fitness to drive and prepared early for the possibility that they may not be able to drive, at some point in the future. This should occur not only at the time of driver licence renewal, but whenever medical conditions or medications change that may impact on driving ability and safety. View Article

Antipsychotics in people with dementia: an update

The Antipsychotics in Dementia (A4D) programme was launched in October 2008. Since then, the use of antipsychotics in older people has continued to increase. Non-pharmacological treatments for the behavioural and psychological symptoms of dementia should be trialled first before considering drug therapy. Antipsychotics are only indicated for aggression, agitation or psychotic symptoms that cause significant distress or risk of harm to the patient or others. View Article

Time is brain: emergency treatment of stroke

Stroke is the third most common cause of death in New Zealand, with approximately 22 strokes occurring each day. Stroke should be dealt with immediately - “time is brain”. Patients with symptoms suggestive of stroke should be referred to secondary care management without delay. View Article

Secondary stroke prevention

People who have had a stroke or transient ischaemic attack are at increased risk of future stroke, especially in the first few months. A further stroke may be preventable if risk reduction strategies are undertaken. Secondary stroke prevention includes lifestyle interventions, blood pressure management, antithrombotic treatment and lipid lowering agents. View Article

Upfront: Results from the 2009 bpacnz survey

A SINCERE THANK YOU to everyone who contributed to the end of year bpacnz survey. We had an overwhelming response (over 1500 responses to date) and we are currently analysing the results, but here is a sneak peek. . . View Article

Practice snippets

Dextropropoxyphene-containing medicines to be withdrawn | Sibutramine (Reductil) withdrawn from European markets | Mirtazapine newly funded on special authority View Article

Quiz feedback: Chronic kidney disease and oral health

This quiz was based on content from "Making a difference in chronic kidney disease" and "Oral health – The challenge" in BPJ 22 (July 2009). View Article